title: [Triamcinolone acetonide bevacizumab performance in treatment and idiopathic macular spider veins].
abstract: This article evaluated the efficacy of intravitrean injection of anti VEGF agents and triamcinolon in the treatment of macular telangiectasis. The patients were followed six months. We practiced fluorescein angiography, optical coherence tomography. We measured the thickening of macular edema and best corrected of visual acuity.
authors.affiliation: Clinica Laser Optics Bucuresti.
authors.forename: Beatrice
authors.initials: B
authors.lastname: Cerbulescu
authors.forename: Ana-Lavinia
authors.initials: AL
authors.lastname: Taina
authors.forename: Monica
authors.initials: M
authors.lastname: Dinita
authors.forename: Raluca
authors.initials: R
authors.lastname: Malaeanu
authors.forename: Robertina
authors.initials: R
authors.lastname: Radocea
authors.forename: B
authors.initials: B
authors.lastname: Carstocea
mesh_terms: D000328:Adult; D020533:Angiogenesis Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D004359:Drug Therapy, Combination; D005938:Glucocorticoids / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D056965:Injections, Intraocular; D008269:Macular Edema / Q000175:diagnosis / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D013684:Telangiectasis / Q000175:diagnosis / Q000188:drug therapy*; D041623:Tomography, Optical Coherence; D016896:Treatment Outcome; D014222:Triamcinolone Acetonide / Q000008:administration & dosage / Q000627:therapeutic use*; D014792:Visual Acuity
chemical_list: D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D005938:Glucocorticoids; D000068258:Bevacizumab; D014222:Triamcinolone Acetonide